Genetics and Genomics in EGFR-Mutant Lung Cancer

Learn about the genetic and genomic aspects of EGFR-mutant lung cancer in this 12-minute patient forum presentation by Dr. Jaclyn LoPiccolo, MD, PhD, from the Dana-Farber Cancer Institute. Explore the fundamental concepts of genetics and genomics as they relate specifically to EGFR mutations in lung cancer, gaining insights into how these genetic alterations impact cancer development, progression, and treatment approaches. Discover the latest understanding of EGFR mutations and their role in personalized cancer care, presented in an accessible format designed for patients and families affected by EGFR-mutant lung cancer. This educational session was part of the 2025 Living with EGFR-Mutant Lung Cancer Patient Forum hosted by the Chen-Huang Center at Dana-Farber Cancer Institute.